NCT03043638

Brief Summary

The aim of this study was to evaluate the effectiveness of platelet rich plasma (PRP) combined with coronally advanced flap plus acellular dermal matrix application (CAF+ADM) in the treatment of multiple adjacent gingival recessions (MAGRs). 12 patients with 84 Miller Class I or II recession defects were participated. Sites were randomly assigned into CAF+ADM+PRP or CAF+ADM groups. Gingival recession depth (GRD), recession width (GRW), width of keratinized tissue (WKT), creeping attachment (CRA), root coverage (RC) as well as plaque index, gingival index, probing depth (PD), and clinical attachment level (CAL) were recorded at baseline and 3rd,6th and 12th months postoperatively. The data were analyzed statistically.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2008

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2011

Completed
5.6 years until next milestone

First Submitted

Initial submission to the registry

February 2, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 6, 2017

Completed
Last Updated

February 8, 2017

Status Verified

January 1, 2017

Enrollment Period

3 years

First QC Date

February 2, 2017

Last Update Submit

February 6, 2017

Conditions

Keywords

multiple adjacent gingival recessionsplatelet rich plasmaacellular dermal matrixcoronally advanced flapgingival recessionroot coverageclinical attachment level

Outcome Measures

Primary Outcomes (1)

  • Root coverage (RC)

    The percentage of root coverage (RC) was calculated as (\[GRD preoperation - GRD postoperation\] / GRD preoperation) x 100%.

    The change in RC at 3rd month to 12th month

Secondary Outcomes (6)

  • Gingival recession depth (GRD)

    Baseline, 3,6 and 12 months after periodontal surgery

  • recession width (GRW)

    Baseline, 3,6 and 12 months after periodontal surgery

  • width of keratinized tissue (WKT)

    Baseline, 3,6 and 12 months after periodontal surgery

  • plaque index(PI)

    Baseline, 3,6 and 12 months after periodontal surgery

  • gingival index

    Baseline, 3,6 and 12 months after periodontal surgery

  • +1 more secondary outcomes

Study Arms (2)

CAF+ADM+PRP

EXPERIMENTAL

Surgery will include Coronally advanced flap(CAF) plus acellular dermal matrix (ADM) combined with platelet rich plasma (PRP)

Procedure: CAF+ADM+PRP

CAF+ADM

ACTIVE COMPARATOR

Surgery will include only Coronally advanced flap CAF technique including ADM placement without PRP

Procedure: CAF+ADM

Interventions

CAF+ADM+PRPPROCEDURE

CAF+ADM+PRP group treated with coronally advanced flap technique including ADM placement, In CAF+ADM+PRP group, ADM was hydrated in the platelet-poor plasma (PPP) and the PRP was applied to surgical sites prior to final suturing.

CAF+ADM+PRP
CAF+ADMPROCEDURE

CAF+ADM group treated with coronally advanced flap technique including ADM placement without PRP application

CAF+ADM

Eligibility Criteria

Age34 Years - 57 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Clinical diagnosis of the presence of at least three multiple adjacent Miller class I or II recessions on both sides of the same maxillary or mandibular arch
  • must be able to have 2 mm-high keratinized tissue apical to the root exposures;
  • must be able to have no systemic diseases that could influence the outcome of the therapy;
  • must be able to have a full-mouth plaque score of 20% (O'Leary et al. 1972);
  • must be non-smoker;
  • must be not pregnant.

You may not qualify if:

  • debilitating systemic or infectious diseases (human immunodeficiency virus or hepatitis) -- -any disease that significantly affects the periodontium;
  • known allergy to any of the materials used in the study; requirement for antibiotic prophylaxis;
  • taking medications known to interfere with periodontal health and healing not detectable cemento-enamel junction (CEJ);
  • restorations or caries at the recession site;
  • failure to maintain an oral hygiene level ≥80% plaque-free surfaces; pregnancy or lactation; use of tobacco products; alcohol abuse;
  • a previous periodontal surgery at the recession site and failure to complete the informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Shepherd N, Greenwell H, Hill M, Vidal R, Scheetz JP. Root coverage using acellular dermal matrix and comparing a coronally positioned tunnel with and without platelet-rich plasma: a pilot study in humans. J Periodontol. 2009 Mar;80(3):397-404. doi: 10.1902/jop.2009.080438.

    PMID: 19254123BACKGROUND
  • Cetiner D, Gokalp Kalabay P, Ozdemir B, Cankaya ZT. Efficiency of platelet-rich plasma on acellular dermal matrix application with coronally advanced flap in the treatment of multiple adjacent gingival recessions: A randomized controlled clinical trial. J Dent Sci. 2018 Sep;13(3):198-206. doi: 10.1016/j.jds.2017.11.002. Epub 2018 Feb 3.

MeSH Terms

Conditions

Gingival Recession

Condition Hierarchy (Ancestors)

Gingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal Atrophy

Study Officials

  • Pelin Gokalp

    Gazi University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 2, 2017

First Posted

February 6, 2017

Study Start

July 1, 2008

Primary Completion

June 20, 2011

Study Completion

June 20, 2011

Last Updated

February 8, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will share

When needed data can be shared via email.